Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04134000
Title Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE) (BladderGATE)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fundacion Oncosur
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab + BCG solution

Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.